Sunday, March 26, 2017 1:22:59 PM
http://www.nytimes.com/1995/11/07/business/cordis-to-be-acquired-by-johnson-johnson.html
Imo his current company, US Stem Cell has much greater potential. Adjust for inflation. That is why you see these predictions. I'm just gonna ride my free shares from here, imo the potential is great but I won't put a price on it until we have some type of FDA news. Which could be very soon
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM